Development of a G2/M arrest high-throughput screening method identifies potent radiosensitizers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a G2/M arrest high-throughput screening method identifies potent radiosensitizers

Published:2022-02 Issue: Volume:16 Page:101336
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Landry Madeleine,Nelson Dylan,Choi Eunseo,DuRoss Allison,Sun Conroy

Funder

Oregon State University

National Institutes of Health

National Institute of General Medical Sciences

PhRMA Foundation

American Foundation for Pharmaceutical Education

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Clinical Development of Novel Drug-Radiotherapy Combinations;Ahmad;Clin. Cancer Res.,2019

2. Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers;Buckley;Nat. Rev. Gastroenterol. Hepatol.,2020

3. Clinical development of new drug–radiotherapy combinations;Sharma;Nat. Rev. Clin. Oncol.,2016

4. Dihydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening;Li;Radiother. Oncol.,2020

5. Ro90-7501 Is Identified As a Radiosensitizer By High Throughput Screening;Tamari;Int. J. Radiat. Oncol. Biol. Phys.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular Effects of Cationic Copper(II) Schiff Base Complexes: Anti‐Inflammatory and Antiproliferative Properties;ChemMedChem;2024-08-09

2. Effects of PreOperative radiotherapy in a preclinical glioblastoma model: a paradigm-shift approach;Journal of Neuro-Oncology;2024-07-22

3. P53 status, and G2/M cell cycle arrest, are determining factors in cell-death induction mediated by ELF-EMF in glioblastoma;Scientific Reports;2023-07-05

4. Structure-based virtual screening of chemical libraries as potential MELK inhibitors and their therapeutic evaluation against breast cancer;Chemico-Biological Interactions;2023-05

5. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation;Chemical Society Reviews;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3